Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ACHIEVE LIFE SCIENCES, INC.ACHV · Entity 5072 | Director | May 12, 2020 | May 14, 2020 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ACHIEVE LIFE SCIENCES, INC.
Report date May 12, 2020 · Filed May 14, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.43 · Expires 2030-05-12 | Direct | 22,000 |
Reported balance
After 2020-05-12 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2020-05-12 · Grant · Acquired 22,000 · Balance 22,000 F1: The options vest 100% on the earlier of May 12, 2021 or the date immediately prior to the Issuer's next annual meeting of stockholders. |
Filing footnotes · ownership attribution and instrument terms
F1: The options vest 100% on the earlier of May 12, 2021 or the date immediately prior to the Issuer's next annual meeting of stockholders.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 12, 2020 Filed May 14, 2020 20:10 UTC | ACHIEVE LIFE SCIENCES, INC. ACHV · Entity 5072 | GrantStock Option (right to buy) · Derivative | 22,000 | $0.00 Strike: $0.43 | $0.00 |
DisclosureSEC source: 0001209191-20-029159 · doc4.xml · derivative · entry 1 Cormack Scott Daniel · CIK 0001442675 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,000 Underlying: Common Stock · 22,000 shares Expires 2030-05-12 F1 · derivative.exercise_date: The options vest 100% on the earlier of May 12, 2021 or the date immediately prior to the Issuer's next annual meeting of stockholders. Read SEC document |
| May 14, 2019 Filed May 15, 2019 20:41 UTC | ACHIEVE LIFE SCIENCES, INC. ACHV · Entity 5072 | GrantStock Option (right to buy) · Derivative | 7,000 | $0.00 Strike: $4.02 | $0.00 |
DisclosureSEC source: 0001209191-19-030038 · doc4.xml · derivative · entry 1 Cormack Scott Daniel · CIK 0001442675 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,000 Underlying: Common Stock · 7,000 shares Expires 2029-05-14 F1 · derivative.exercise_date: The options vest 100% on the earlier of May 14, 2020 or the date immediately prior to the Issuer's next annual meeting of stockholders. Read SEC document |
| September 20, 2018 Filed Sep 21, 2018 20:40 UTC | ACHIEVE LIFE SCIENCES, INC. ACHV · Entity 5072 | GrantStock Option (right to buy) · Derivative | 12,000 | $0.00 Strike: $2.56 | $0.00 |
DisclosureSEC source: 0001209191-18-051899 · doc4.xml · derivative · entry 1 Cormack Scott Daniel · CIK 0001442675 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,000 Underlying: Common Stock · 12,000 shares Expires 2028-09-20 F1 · derivative.exercise_date: The options vest in monthly installments over one year commencing one month from September 20 2018. Read SEC document |
| October 10, 2017 Filed Jan 12, 2017 16:31 UTC | ACHIEVE LIFE SCIENCES, INC. OGXI · Entity 5072 | Exercise / conversionRestricted Stock Unit (RSU) · Derivative | 4,687 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-003460 · doc4.xml · derivative · entry 9 Cormack Scott Daniel · CIK 0001442675 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 9,375 Underlying: Common Stock · 4,687 shares Expires 2019-06-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock at settlement. F6 · derivative.exercise_date: Pursuant to the terms of the RSU, 25% of the total shares underlying the RSU vest annually on the later of (i) each anniversary of January 1, 2015; and (ii) the first day thereafter during which the issuer's trading window is open. Read SEC document |
| October 10, 2017 Filed Jan 12, 2017 16:31 UTC | ACHIEVE LIFE SCIENCES, INC. OGXI · Entity 5072 | Exercise / conversionRestricted Stock Unit (RSU) · Derivative | 3,125 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-003460 · doc4.xml · derivative · entry 8 Cormack Scott Daniel · CIK 0001442675 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 3,125 Underlying: Common Stock · 3,125 shares Expires 2018-04-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock at settlement. F5 · derivative.exercise_date: Pursuant to the terms of the RSU, 25% of the total shares underlying the RSU vest annually on the later of (i) each anniversary of January 1, 2014; and (ii) the first day thereafter during which the issuer's trading window is open. Read SEC document |
| September 08, 2017 Filed Sep 12, 2017 18:28 UTC | ACHIEVE LIFE SCIENCES, INC. ACHV · Entity 5072 | Tax withholdingCommon Stock | 1,491 | $3.09 | $4,607.19 |
DisclosureSEC source: 0001209191-17-052370 · doc4.xml · nonDerivative · entry 1 Cormack Scott Daniel · CIK 0001442675 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,810 F1 · shares: Represents shares of common stock that have been withheld by the issuer to satisfy its income tax withholding obligations in connection with the net settlement of restricted stock units reported by the reporting holder on August 3, 2017 in connection with the consummation of the merger on August 1, 2017 between OncoGenex Pharmaceuticals, Inc. and Achieve Life Science, Inc. and does not represent a sale by the reporting person. Read SEC document |
| August 01, 2017 Filed Aug 4, 2017 00:58 UTC | ACHIEVE LIFE SCIENCES, INC. ACHV · Entity 5072 | GrantStock Option (right to buy) · Derivative | 11,000 | $0.00 Strike: $4.57 | $0.00 |
DisclosureSEC source: 0001209191-17-047593 · doc4.xml · derivative · entry 9 Cormack Scott Daniel · CIK 0001442675 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,000 Underlying: Common Stock · 11,000 shares Expires 2027-08-01 Read SEC document |
| August 01, 2017 Filed Aug 4, 2017 00:58 UTC | ACHIEVE LIFE SCIENCES, INC. ACHV · Entity 5072 | Exercise / conversionRestricted Stock Unit (RSU) · Derivative | 454 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-047593 · doc4.xml · derivative · entry 8 Cormack Scott Daniel · CIK 0001442675 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 0 Underlying: Common Stock · 454 shares Expires 2018-06-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the issuer's common stock at settlement. F5 · derivative.exercise_date: Pursuant to the terms of the reporting holder's spouse's consulting agreement, the RSU immediately vested on August 1, 2017, in connection with the consummation of the Merger. F4 · derivative.underlying_shares: Reflects the Reverse Stock Split. Read SEC document |
| August 01, 2017 Filed Aug 4, 2017 00:58 UTC | ACHIEVE LIFE SCIENCES, INC. ACHV · Entity 5072 | Exercise / conversionRestricted Stock Unit (RSU) · Derivative | 852 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-047593 · doc4.xml · derivative · entry 7 Cormack Scott Daniel · CIK 0001442675 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 0 Underlying: Common Stock · 852 shares Expires 2019-06-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the issuer's common stock at settlement. F5 · derivative.exercise_date: Pursuant to the terms of the reporting holder's spouse's consulting agreement, the RSU immediately vested on August 1, 2017, in connection with the consummation of the Merger. F4 · derivative.underlying_shares: Reflects the Reverse Stock Split. Read SEC document |
| August 01, 2017 Filed Aug 4, 2017 00:58 UTC | ACHIEVE LIFE SCIENCES, INC. ACHV · Entity 5072 | Exercise / conversionRestricted Stock Unit (RSU) · Derivative | 284 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-047593 · doc4.xml · derivative · entry 6 Cormack Scott Daniel · CIK 0001442675 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 0 Underlying: Common Stock · 284 shares Expires 2018-04-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the issuer's common stock at settlement. F5 · derivative.exercise_date: Pursuant to the terms of the reporting holder's spouse's consulting agreement, the RSU immediately vested on August 1, 2017, in connection with the consummation of the Merger. F4 · derivative.underlying_shares: Reflects the Reverse Stock Split. Read SEC document |
| August 01, 2017 Filed Aug 4, 2017 00:58 UTC | ACHIEVE LIFE SCIENCES, INC. ACHV · Entity 5072 | Exercise / conversionRestricted Stock Unit (RSU) · Derivative | 852 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-047593 · doc4.xml · derivative · entry 5 Cormack Scott Daniel · CIK 0001442675 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 852 shares Expires 2018-06-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the issuer's common stock at settlement. F3 · derivative.exercise_date: Pursuant to the terms of the reporting holder's employment agreement, the RSUs immediately vested in full on August 1, 2017, in connection with the consummation of the Merger. F4 · derivative.underlying_shares: Reflects the Reverse Stock Split. Read SEC document |
| August 01, 2017 Filed Aug 4, 2017 00:58 UTC | ACHIEVE LIFE SCIENCES, INC. ACHV · Entity 5072 | Exercise / conversionRestricted Stock Unit (RSU) · Derivative | 1,705 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-047593 · doc4.xml · derivative · entry 4 Cormack Scott Daniel · CIK 0001442675 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,705 shares Expires 2019-06-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the issuer's common stock at settlement. F3 · derivative.exercise_date: Pursuant to the terms of the reporting holder's employment agreement, the RSUs immediately vested in full on August 1, 2017, in connection with the consummation of the Merger. F4 · derivative.underlying_shares: Reflects the Reverse Stock Split. Read SEC document |
| August 01, 2017 Filed Aug 4, 2017 00:58 UTC | ACHIEVE LIFE SCIENCES, INC. ACHV · Entity 5072 | Exercise / conversionRestricted Stock Unit (RSU) · Derivative | 568 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-047593 · doc4.xml · derivative · entry 3 Cormack Scott Daniel · CIK 0001442675 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 568 shares Expires 2018-04-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the issuer's common stock at settlement. F3 · derivative.exercise_date: Pursuant to the terms of the reporting holder's employment agreement, the RSUs immediately vested in full on August 1, 2017, in connection with the consummation of the Merger. F4 · derivative.underlying_shares: Reflects the Reverse Stock Split. Read SEC document |
| August 01, 2017 Filed Aug 4, 2017 00:58 UTC | ACHIEVE LIFE SCIENCES, INC. ACHV · Entity 5072 | Exercise / conversionCommon Stock | 1,590 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-047593 · doc4.xml · nonDerivative · entry 2 Cormack Scott Daniel · CIK 0001442675 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 9,685 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares of common stock acquired upon settlement of the restricted stock units ("RSUs") listed in Table II. On August 1, 2017, the effective date of the merger between OncoGenex Pharmaceuticals, Inc. and Achieve Life Science, Inc. (the "Merger"), the closing price of Achieve Life Sciences, Inc.'s common stock was $4.576 per share, representing a closing price of $0.416 per share of Oncogenex common stock as adjusted to reflect an 11-to-1 reverse stock split effected on August 1, 2017 (the "Reverse Stock Split"). Read SEC document |
| August 01, 2017 Filed Aug 4, 2017 00:58 UTC | ACHIEVE LIFE SCIENCES, INC. ACHV · Entity 5072 | Exercise / conversionCommon Stock | 3,125 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-047593 · doc4.xml · nonDerivative · entry 1 Cormack Scott Daniel · CIK 0001442675 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,302 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares of common stock acquired upon settlement of the restricted stock units ("RSUs") listed in Table II. On August 1, 2017, the effective date of the merger between OncoGenex Pharmaceuticals, Inc. and Achieve Life Science, Inc. (the "Merger"), the closing price of Achieve Life Sciences, Inc.'s common stock was $4.576 per share, representing a closing price of $0.416 per share of Oncogenex common stock as adjusted to reflect an 11-to-1 reverse stock split effected on August 1, 2017 (the "Reverse Stock Split"). Read SEC document |
| August 01, 2017 Filed Sep 12, 2017 18:46 UTC Amendment | ACHIEVE LIFE SCIENCES, INC. ACHV · Entity 5072 | GrantStock Option (right to buy) · Derivative | 11,000 | $0.00 Strike: $2.89 | $0.00 |
DisclosureSEC source: 0001209191-17-052377 · doc4a.xml · derivative · entry 1 Cormack Scott Daniel · CIK 0001442675 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,000 Underlying: Common Stock · 11,000 shares Expires 2027-08-01 F1 · derivative.exercise_price: This amended Form 4 is filed to correct the exercise price to reflect that the grant was effective as of the issuer's first open trading window after approval of the grant. All other terms remain the same. Read SEC document |
| June 12, 2017 Filed Jun 14, 2017 20:39 UTC | ACHIEVE LIFE SCIENCES, INC. OGXI · Entity 5072 | Exercise / conversionRestricted Stock Unit (RSU) · Derivative | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-039846 · doc4.xml · derivative · entry 5 Cormack Scott Daniel · CIK 0001442675 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2018-06-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock at settlement. F4 · derivative.exercise_date: Pursuant to the terms of the RSU, 25% of the total shares underlying the RSU vest annually each anniversary of June 12, 2014, subject to the reporting person's provision of service to the issuer on each vesting date. Read SEC document |
| June 12, 2017 Filed Jun 14, 2017 20:39 UTC | ACHIEVE LIFE SCIENCES, INC. OGXI · Entity 5072 | Exercise / conversionRestricted Stock Unit (RSU) · Derivative | 9,375 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-039846 · doc4.xml · derivative · entry 4 Cormack Scott Daniel · CIK 0001442675 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,375 Underlying: Common Stock · 9,375 shares Expires 2018-06-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock at settlement. F4 · derivative.exercise_date: Pursuant to the terms of the RSU, 25% of the total shares underlying the RSU vest annually each anniversary of June 12, 2014, subject to the reporting person's provision of service to the issuer on each vesting date. Read SEC document |
| June 12, 2017 Filed Jun 14, 2017 20:39 UTC | ACHIEVE LIFE SCIENCES, INC. OGXI · Entity 5072 | Exercise / conversionCommon Stock | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-039846 · doc4.xml · nonDerivative · entry 3 Cormack Scott Daniel · CIK 0001442675 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 89,055 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares of common stock acquired upon settlement of the restricted stock units ("RSUs") listed in Table II. Read SEC document |
| June 12, 2017 Filed Jun 14, 2017 20:39 UTC | ACHIEVE LIFE SCIENCES, INC. OGXI · Entity 5072 | Tax withholdingCommon Stock | 4,472 | $0.36 | $1,609.92 |
DisclosureSEC source: 0001209191-17-039846 · doc4.xml · nonDerivative · entry 2 Cormack Scott Daniel · CIK 0001442675 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 144,953 F2 · shares: Represents shares of common stock that have been withheld by the issuer to satisfy the tax liability in connection with the settlement of RSUs and does not represent a sale by the reporting person. Read SEC document |
| June 12, 2017 Filed Jun 14, 2017 20:39 UTC | ACHIEVE LIFE SCIENCES, INC. OGXI · Entity 5072 | Exercise / conversionCommon Stock | 9,375 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-039846 · doc4.xml · nonDerivative · entry 1 Cormack Scott Daniel · CIK 0001442675 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 149,425 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares of common stock acquired upon settlement of the restricted stock units ("RSUs") listed in Table II. Read SEC document |
| January 10, 2017 Filed Jan 12, 2017 16:31 UTC | ACHIEVE LIFE SCIENCES, INC. OGXI · Entity 5072 | Exercise / conversionRestricted Stock Unit · Derivative | 2,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-003460 · doc4.xml · derivative · entry 7 Cormack Scott Daniel · CIK 0001442675 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 0 Underlying: Common Stock · 2,500 shares Expires 2017-01-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock at settlement. F4 · derivative.exercise_date: Pursuant to the terms of the RSU, 25% of the total shares underlying the RSU vest annually on the later of (i) each anniversary of January 1, 2013; and (ii) the first day thereafter during which the issuer's trading window is open. Read SEC document |
| January 10, 2017 Filed Jan 12, 2017 16:31 UTC | ACHIEVE LIFE SCIENCES, INC. OGXI · Entity 5072 | Exercise / conversionRestricted Stock Unit (RSU) · Derivative | 9,375 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-003460 · doc4.xml · derivative · entry 6 Cormack Scott Daniel · CIK 0001442675 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,750 Underlying: Common Stock · 9,375 shares Expires 2019-06-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock at settlement. F6 · derivative.exercise_date: Pursuant to the terms of the RSU, 25% of the total shares underlying the RSU vest annually on the later of (i) each anniversary of January 1, 2015; and (ii) the first day thereafter during which the issuer's trading window is open. Read SEC document |
| January 10, 2017 Filed Jan 12, 2017 16:31 UTC | ACHIEVE LIFE SCIENCES, INC. OGXI · Entity 5072 | Exercise / conversionRestricted Stock Unit (RSU) · Derivative | 6,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-003460 · doc4.xml · derivative · entry 5 Cormack Scott Daniel · CIK 0001442675 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,250 Underlying: Common Stock · 6,250 shares Expires 2018-04-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock at settlement. F5 · derivative.exercise_date: Pursuant to the terms of the RSU, 25% of the total shares underlying the RSU vest annually on the later of (i) each anniversary of January 1, 2014; and (ii) the first day thereafter during which the issuer's trading window is open. Read SEC document |
| January 10, 2017 Filed Jan 12, 2017 16:31 UTC | ACHIEVE LIFE SCIENCES, INC. OGXI · Entity 5072 | Exercise / conversionRestricted Stock Unit (RSU) · Derivative | 4,687 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-003460 · doc4.xml · derivative · entry 4 Cormack Scott Daniel · CIK 0001442675 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,687 shares Expires 2017-01-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock at settlement. F4 · derivative.exercise_date: Pursuant to the terms of the RSU, 25% of the total shares underlying the RSU vest annually on the later of (i) each anniversary of January 1, 2013; and (ii) the first day thereafter during which the issuer's trading window is open. Read SEC document |
| January 10, 2017 Filed Jan 12, 2017 16:31 UTC | ACHIEVE LIFE SCIENCES, INC. OGXI · Entity 5072 | Exercise / conversionCommon Stock | 10,312 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-003460 · doc4.xml · nonDerivative · entry 3 Cormack Scott Daniel · CIK 0001442675 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 84,055 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares of common stock acquired upon settlement of the restricted stock units ("RSUs") listed in Table II. Read SEC document |
| January 10, 2017 Filed Jan 12, 2017 16:31 UTC | ACHIEVE LIFE SCIENCES, INC. OGXI · Entity 5072 | Tax withholdingCommon Stock | 9,690 | $0.63 | $6,104.70 |
DisclosureSEC source: 0001209191-17-003460 · doc4.xml · nonDerivative · entry 2 Cormack Scott Daniel · CIK 0001442675 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,050 F2 · shares: Represents shares of common stock that have been withheld by the issuer to satisfy the tax liability in connection with the settlement of RSUs. Read SEC document |
| January 10, 2017 Filed Jan 12, 2017 16:31 UTC | ACHIEVE LIFE SCIENCES, INC. OGXI · Entity 5072 | Exercise / conversionCommon Stock | 20,312 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-003460 · doc4.xml · nonDerivative · entry 1 Cormack Scott Daniel · CIK 0001442675 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 149,740 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares of common stock acquired upon settlement of the restricted stock units ("RSUs") listed in Table II. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.